Successful Capecitabine Desensitization for a Delayed-Type Hypersensitivity Reaction.

Demir, S; Olgac, M; Saglam, S; Gelincik, A; Colakoglu, B; Buyukozturk, S

Demir, S; Olgac, M; Saglam, S; Gelincik, A; Colakoglu, B; Buyukozturk, S.

J Investig Allergol Clin Immunol ; 26(1): 66-7, 2016.

Article in En | MEDLINE | ID: mdl-27012024

Subject(s)

Antimetabolites, Antineoplastic/adverse effects; Capecitabine/adverse effects; Colonic Neoplasms/drug therapy; Desensitization, Immunologic/methods; Drug Eruptions/therapy; Hypersensitivity, Delayed/therapy; Skin/drug effects; Aged; Antimetabolites, Antineoplastic/administration & dosage; Antimetabolites, Antineoplastic/immunology; Capecitabine/administration & dosage; Capecitabine/immunology; Colonic Neoplasms/pathology; Drug Administration Schedule; Drug Eruptions/diagnosis; Drug Eruptions/immunology; Humans; Hypersensitivity, Delayed/diagnosis; Hypersensitivity, Delayed/immunology; Immune Tolerance; Intradermal Tests; Male; Skin/immunology; Skin/pathology; Time Factors; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Skin / Desensitization, Immunologic / Drug Eruptions / Colonic Neoplasms / Capecitabine / Hypersensitivity, Delayed / Antimetabolites, Antineoplastic Type of study: Diagnostic_studies Limits: Aged / Humans / Male Language: En Journal: J Investig Allergol Clin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2016 Document type: Article

Search on Google

Add to My VHL

XML

PubMed Links